THYROID EYE DISEASE
Clinical trials for THYROID EYE DISEASE explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers test cutting treatment time in half for eye disease
Disease control Not yet recruitingThis study aims to see if a shorter treatment course works as well as the standard one for thyroid eye disease. It will involve 40 patients who show a good early response to the medication. Researchers will compare outcomes between patients receiving 4 infusions versus the usual …
Matched conditions: THYROID EYE DISEASE
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial targets bulging eyes in thyroid disease
Disease control Not yet recruitingThis early-stage study is testing an investigational drug called NTB003 for people with moderate-to-severe Thyroid Eye Disease (TED). The main goal is to see if the drug is safe and if it can reduce eye bulging and inflammation. The study will enroll about 74 adults who have had …
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Second chance treatment tested for stubborn thyroid eye condition
Disease control Not yet recruitingThis study is testing whether the drug AMG 732 can help people with thyroid eye disease whose eye bulging didn't improve or returned after previous treatment. The trial includes 30 adults who participated in an earlier AMG 732 study but didn't respond well or had their symptoms c…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New eye bulging treatment tested against standard care
Disease control Not yet recruitingThis study aims to see if a new drug called teprotumumab N01 works better than standard steroid treatment for controlling active Thyroid Eye Disease. About 92 adults with moderate-to-severe, recently active disease will be randomly assigned to receive either the new drug or the s…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE4 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC